Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Summary

A new article on Zip Nucleic Acid (ZNA®) has been published in The Glen Report of May 2016 (Volume 28, Number 1). ZNA® are powerful cationic oligonucleotides especially designed for molecular biology, diagnostic and therapeutic applications.

ZNA molecules

ZNA® are a novel class of modified oligonucleotides enhancing hybridization properties of nucleic acids. ZNA® are oligonucleotides conjugated to cationic units. Their global charge can be modulated by the number of cationic spermine moieties grafted on each oligonucleotide. The ZNA® technology is applicable to any application involving oligonucleotides. However, the global charge of ZNA defines per se the fields of applications.

When negatively charged, ZNA® conserve their ability to mediate specific hybridization with complementary strands and they are more suitable for PCR applications, amplifications techniques, and diagnostic applications or purifications technologies.

Structure of a ZNA molecule

On the contrary, positively charged ZNA® are more likely to mediate first a non-specific binding/interaction with polyanions through electrostatic interactions before their possible specific hybridization to a target sequence through bases pairing. ZNA® molecules bearing excess of cationic charges were shown to have the property to stick to anionic cells surface and to trigger endocytosis, leading to cell transfection without the need of a transfection reagent (or a cargo). ZNA®-based siRNAs or antisenses were shown to perform effective and specific gene silencing and inhibition in animal cells.

ZNA hybridization

About Glen Research

Glen Research is a biotechnology company that develops and sells material used for diagnostics, sequencing and therapeutics. This Polyplus-transfection partner has added ZNA® to its large range of products after recognizing its efficiency. Twice a year, Glen Research publishes a report presenting different technologies and this year, ZNA® is featured!

Glen Research logo

Many scientific publications have been released regarding ZNA®. You can see some publications in the ZNA® page in the tab “citations”.

Please feel free to see more information about the article at: http://www.glenresearch.com/GlenReports/GR28-11.html

Learn more

Resources

Articles

ZNA® for diagnostic and therapeutic applications

Pressroom

Polyplus-transfection announces the development of ZNA™

View All Resources